Long-term experience with biologic therapies for the treatment of polyarticular juvenile idiopathic arthritis

Author： Klein Ariane   Horneff Gerd  

Publisher： Future Science

ISSN： 2041-6792

Source： Clinical Investigation, Vol.3, Iss.5, 2013-05, pp. : 493-504

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Radiological improvement by tocilizumab in polyarticular juvenile idiopathic arthritis

By  

PEDIATRICS INTERNATIONAL, Vol. 57, Iss. 2, 2015-04 ,pp. : 307-310

John Wiley & Sons Inc

Access to resources Recommend Favorite

Childhood Arthritis and Rheumatology Research Alliance Consensus Treatment Plans for New‐Onset Polyarticular Juvenile Idiopathic Arthritis

By  

ARTHRITIS CARE AND RESEARCH, Vol. 66, Iss. 7, 2014-07 ,pp. : 1063-1072

John Wiley & Sons Inc

Access to resources Recommend Favorite

The Biologic Basis of Clinical Heterogeneity in Juvenile Idiopathic Arthritis

By  

ARTHRITIS & RHEUMATOLOGY, Vol. 66, Iss. 12, 2014-12 ,pp. : 3463-3475

John Wiley & Sons Inc

Access to resources Recommend Favorite

Children with juvenile idiopathic arthritis frequently experience interruptions to their medical therapy

By  

ACTA PAEDIATRICA, Vol. 103, Iss. 5, 2014-05 ,pp. : 529-536

John Wiley & Sons Inc

Access to resources Recommend Favorite

Efficacy and Safety of Adalimumab as the First and Second Biologic Agent in Juvenile Idiopathic Arthritis: The German Biologics JIA Registry

By  

ARTHRITIS & RHEUMATOLOGY, Vol. 66, Iss. 9, 2014-09 ,pp. : 2580-2589

John Wiley & Sons Inc

Access to resources Recommend Favorite